ATR and breast cancer: VE-821 also decreased dCK activity in chronic lymphocytic leukemia cells (EHEB), HL-60 cells, breast cancer cells (MCF-7), and pancreatic cancer cells (PANC-1), indicating that the regulation of dCK activity by ATR was generalized to various cell types12.